Guanhao Biotech Co (SZSE:300238) Receivables Turnover : 1.61 (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is Guanhao Biotech Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Guanhao Biotech Co's Revenue for the three months ended in Mar. 2025 was ¥94.8 Mil. Guanhao Biotech Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥58.7 Mil. Hence, Guanhao Biotech Co's Receivables Turnover for the three months ended in Mar. 2025 was 1.61.

Guanhao Biotech Co Receivables Turnover Historical Data

The historical data trend for Guanhao Biotech Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guanhao Biotech Co Receivables Turnover Chart

Guanhao Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

3.50

4.38

4.22

6.07

6.26

Guanhao Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Receivables Turnover	Get a 7-Day Free Trial															1.35	1.45	1.42	1.61	1.61

Competitive Comparison of Guanhao Biotech Co's Receivables Turnover

For the Biotechnology subindustry, Guanhao Biotech Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guanhao Biotech Co's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guanhao Biotech Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Guanhao Biotech Co's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Guanhao Biotech Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Guanhao Biotech Co's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	377.483	/ (	(61.143	+	59.546)	/	2 )
=	377.483	/	60.3445
=	6.26

Guanhao Biotech Co's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

	Receivables Turnover (Q: Mar. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2025 )	/ (	(Accounts Receivable (Q: Dec. 2024 )	+	Accounts Receivable (Q: Mar. 2025 ))	/	count )
=	94.797	/ (	(59.546	+	57.947)	/	2 )
=	94.797	/	58.7465
=	1.61

Guanhao Biotech Co (SZSE:300238) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Guanhao Biotech Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Guanhao Biotech Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Guanhao Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guanhao Biotech Co Ltd (SZSE:300238) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.12 Yuyan Road, Luogang District, Guangdong, Guangzhou, CHN, 510530

Website

http://www.grandhopebio.com

Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.

Executives

Liu De Wang	Directors, executives
Zhao Jun Hui	Directors, executives
Yang Guo Sheng	Supervisors
Zhu Wei Ping	Director
Hu Jun	Securities Affairs Representative
Jia Bao Rong	Executives
Jia Jun Chao	Executives
Di Pu	Director
Zhuo Fu Min	Director
Guo Xiao Ming	Executives
Zhang Hong Tao	Executives
Zhao Wen Jie	Executives
Guan Xin	Director

Guanhao Biotech Co Headlines

No Headlines